Acute Lymphoblastic Leukemia In Remission: Disease Bioinformatics
Acute Lymphoblastic Leukemia is a fast growing type of blood cancer. The cancer is characterized by the high levels of lymphoblasts in both the blood and bone marrow. The cancer can then spread to other organs in the body and without treatment Acute Lymphoblastic Leukemia will progress very quickly. Acute Lymphoblastic Leukemia may arise from transformation of B or T cell progenitor cells. Once there are no traces of leukemia in the body through a series of tests the patient is considered to be in remission. Although it is not guaranteed that the leukemia will continue to be in remission, often a patient will go through a relapse where the cancer returns.
Acute Lymphoblastic Leukemia In Remission Bioinformatics Tool
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Acute Lymphoblastic Leukemia In Remission below!
For more information on how to use Laverne, please read the How to Guide.
We have 1446 products for the study of Acute Lymphoblastic Leukemia In Remission that can be applied to Western Blot, Immunocytochemistry/Immunofluorescence, Flow Cytometry, Immunohistochemistry from our catalog of antibodies and ELISA kits.